ES3017798T3 - Rifamycin analogs in combination with vancomycin and uses thereof - Google Patents

Rifamycin analogs in combination with vancomycin and uses thereof Download PDF

Info

Publication number
ES3017798T3
ES3017798T3 ES22716719T ES22716719T ES3017798T3 ES 3017798 T3 ES3017798 T3 ES 3017798T3 ES 22716719 T ES22716719 T ES 22716719T ES 22716719 T ES22716719 T ES 22716719T ES 3017798 T3 ES3017798 T3 ES 3017798T3
Authority
ES
Spain
Prior art keywords
pharmaceutically acceptable
acceptable salt
amide
ester
vancomycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES22716719T
Other languages
English (en)
Spanish (es)
Inventor
Thomas Nittoli
Anna Zumsteg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regeneron Pharmaceuticals Inc
Original Assignee
Regeneron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals Inc filed Critical Regeneron Pharmaceuticals Inc
Application granted granted Critical
Publication of ES3017798T3 publication Critical patent/ES3017798T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES22716719T 2021-03-26 2022-03-25 Rifamycin analogs in combination with vancomycin and uses thereof Active ES3017798T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163166597P 2021-03-26 2021-03-26
PCT/US2022/021922 WO2022204499A1 (en) 2021-03-26 2022-03-25 Rifamycin analogs in combination with vancomycin and uses thereof

Publications (1)

Publication Number Publication Date
ES3017798T3 true ES3017798T3 (en) 2025-05-13

Family

ID=81308077

Family Applications (1)

Application Number Title Priority Date Filing Date
ES22716719T Active ES3017798T3 (en) 2021-03-26 2022-03-25 Rifamycin analogs in combination with vancomycin and uses thereof

Country Status (14)

Country Link
US (1) US20240189319A1 (https=)
EP (1) EP4313060B1 (https=)
JP (1) JP2024511165A (https=)
KR (1) KR20230162654A (https=)
CN (1) CN117098540A (https=)
AU (1) AU2022246161A1 (https=)
BR (1) BR112023019720A2 (https=)
CA (1) CA3213382A1 (https=)
CL (1) CL2023002840A1 (https=)
CO (1) CO2023013406A2 (https=)
ES (1) ES3017798T3 (https=)
IL (1) IL307220A (https=)
MX (1) MX2023011328A (https=)
WO (1) WO2022204499A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024221162A1 (zh) * 2023-04-24 2024-10-31 丹诺医药(苏州）有限公司 化合物预防关节假体周围感染的方法
KR20260012505A (ko) 2024-07-18 2026-01-27 이화여자대학교 산학협력단 기계 학습을 이용한 반코마이신 초회 투여량 적합성 판단 시스템 및 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118955710A (zh) * 2018-05-09 2024-11-15 里珍纳龙药品有限公司 抗msr1抗体及其使用方法
PH12021551476A1 (en) * 2018-12-21 2022-04-25 Regeneron Pharma Rifamycin analogs and antibody-drug conjugates thereof

Also Published As

Publication number Publication date
US20240189319A1 (en) 2024-06-13
CN117098540A (zh) 2023-11-21
BR112023019720A2 (pt) 2024-01-23
CO2023013406A2 (es) 2023-10-30
AU2022246161A1 (en) 2023-10-12
KR20230162654A (ko) 2023-11-28
CA3213382A1 (en) 2022-09-29
WO2022204499A1 (en) 2022-09-29
MX2023011328A (es) 2023-12-14
CL2023002840A1 (es) 2024-03-15
EP4313060A1 (en) 2024-02-07
IL307220A (en) 2023-11-01
JP2024511165A (ja) 2024-03-12
EP4313060B1 (en) 2025-03-05

Similar Documents

Publication Publication Date Title
ES2640520T3 (es) Compuestos que contienen nitrógeno y su uso
RU2478643C2 (ru) Макроциклические полиморфы, композиции, содержащие такие полиморфы, и способы их применения и получения
JP6215827B2 (ja) キサントン化合物の誘導体
CN108658991B (zh) 3,5-二取代甲基吡唑并[1,5-a]嘧啶-7-酚盐类似物和衍生物制备方法和用途
ES3017798T3 (en) Rifamycin analogs in combination with vancomycin and uses thereof
TWI391135B (zh) 抗菌劑的腸胃外製劑
BR112013012735B1 (pt) Composição farmacêutica inibidora de ss-lactamase
CN108368079A (zh) 治疗细菌感染的化合物及方法
JP2024073569A (ja) 亜鉛イオノフォアおよびその使用
CN103965273B (zh) 一种大环内酯类化合物
CN106414444B (zh) 含氮化合物以及它们的用途
WO2011140009A1 (en) Methods of using semi-synthetic glycopeptides as antibacterial agents
US20170056405A1 (en) Methods and compositions for treating bacterial infection
WO2018045313A1 (en) Substituted urea depsipeptide analogs as activators of the clpp endopeptidase
US10441588B2 (en) Methods and compositions for treating bacterial infection
EP3212183B1 (en) Synergistic compositions for treating microbial infections
ES2942848T3 (es) Derivados de tiofeno-2-amida sustituidos con difenilo y composiciones farmacéuticas de los mismos útiles como antimicrobiano
HK40105351A (en) Rifamycin analogs in combination with vancomycin and uses thereof
HK40105351B (en) Rifamycin analogs in combination with vancomycin and uses thereof
EP3075733A1 (en) Novel heterocyclic compounds and their use in preventing or treating bacterial infections